Abrezekimab Chemical Properties

form 

Liquid

color 

Colorless to light yellow

Abrezekimab Usage And Synthesis

Uses

Abrezekimab (VR 942) contains CDP7766, a humanized, high-affinity, neutralizing, anti-human-IL-13 antibody fragment that binds to IL-13. Abrezekimab prevents binding to the IL-13Rα1 subunit. Abrezekimab can be used in research of asthma[1].

IC 50

IL-13

References

[1] Burgess G, et, al. Randomized study of the safety and pharmacodynamics of inhaled interleukin-13 monoclonal antibody fragment VR942. EBioMedicine. 2018 Sep;35:67-75. DOI:10.1016/j.ebiom.2018.07.035

Abrezekimab(2043952-59-4)Related Product Information

• Ligufalimab
• Gontivimab
• Gresonitamab
• Prolgolimab
• Trevogrumab
• Tosatoxumab
• Vadastuximab
• Sasanlimab
• Geptanolimab
• Tesnatilimab